Eighty-one percent (81/100) of respondents did not have a Biosafety Level 3 (BSL-3) facility within their office to conduct examinations in suspected highly infectious cases; some did have BSL-1 capabilities (40%; 31/77) and BSL-2 capabilities (60%; 46/77).